corpus.blog
43,884 blogs · 5,580,801 posts Claim your blog
Record · corpus.blog/posts/01a0c521-9c42-7037-b699-c52af3cd71c1

Update On Teplizumab from Provention Bio

cureresearch4type1diabetes.blogspot.com · published 22 March 2022

A record is what was published and who pointed at it. The text of the post is not held here: read it at the source, or at its Wayback capture.

Read the post at cureresearch4type1diabetes.blogspot.com Wayback capture
0blogs citing
First cited
—
Most recent
—
Rank this month
not ranked
External links
5
Words captured
2,189

Cited by

No blog we hold has cited this post yet.

Links from this post

Link
Host
http://investors.proventionbio.com/news?l=100&year=2021
investors.proventionbio.com
http://investors.proventionbio.com/2020-11-02-Provention-Bio-Completes-Rolling-Submission-of-the-Biologics-License-Application-BLA-for-Teplizumab-for-the-Delay-or-Prevention-of-Clinical-Type-1-Diabetes-in-At-risk-Individuals
investors.proventionbio.com
http://investors.proventionbio.com/2021-04-08-Provention-Bio-Provides-Regulatory-Update-on-Biologics-License-Application-for-Teplizumab-for-the-Delay-or-Prevention-of-Clinical-Type-1-Diabetes-in-At-Risk-Individuals
investors.proventionbio.com
http://investors.proventionbio.com/2021-04-27-Provention-Bio-Provides-Additional-Regulatory-Update-on-Biologics-License-Application-for-Teplizumab-for-the-Delay-or-Prevention-of-Clinical-Type-1-Diabetes-in-At-Risk-Individuals
investors.proventionbio.com
http://investors.proventionbio.com/2022-01-27-Provention-Bio-Resubmitting-Biologics-License-Application-for-Delay-of-Clinical-Type-1-Diabetes-in-At-Risk-Individuals-Following-Type-B-Meeting-with-the-FDA
investors.proventionbio.com
Elsewhere on cureresearch4type1diabetes.blogspot.com (1)